tradingkey.logo
tradingkey.logo
Search

Edwards Lifesciences Corp

EW
Add to Watchlist
83.800USD
-0.570-0.68%
Close 07-23 16:00ETQuotes delayed by 15 min
48.35BMarket Cap
44.50P/E TTM

EW Financials

See Edwards Lifesciences Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Edwards Lifesciences Corp Earnings Date

Latest Release
Jul 23, 2026
EPS / Forecast
0.42/0.74
Revenue / Forecast
1.74B/1.70B
Period
FY2025 Earnings
Revenue(YoY)
6.07B
11.55%
EPS(YoY)
1.84
-73.72%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-26.07%0.42
7.76%0.66
-75.97%0.16
-90.32%0.50
-6.70%0.57
4.28%0.61
6.95%0.65
710.91%5.14
20.23%0.61
4.36%0.58
-5.96%0.61
--0.63
--0.51
--0.56
--0.65
----
----
----
----
----
----
Revenue
13.63%1.74B
16.70%1.65B
13.26%1.57B
14.67%1.55B
10.56%1.53B
-11.61%1.41B
-9.67%1.39B
8.93%1.35B
6.98%1.39B
9.50%1.60B
13.78%1.53B
-5.73%1.24B
-5.71%1.30B
8.83%1.46B
1.40%1.35B
0.67%1.32B
-0.15%1.37B
10.24%1.34B
11.58%1.33B
14.84%1.31B
----
Net Profit
-27.40%241.90M
6.34%380.70M
-76.35%91.20M
-90.52%291.10M
-9.04%333.20M
1.73%358.00M
4.24%385.60M
697.82%3.07B
19.28%366.30M
3.35%351.90M
-7.15%369.90M
12.05%384.90M
-24.43%307.10M
-8.86%340.50M
18.82%398.40M
1.00%343.50M
-16.98%406.40M
10.47%373.60M
8.34%335.30M
4.58%340.10M
----
Net Margin
-36.75%13.87%
-10.28%23.09%
-83.57%4.09%
-29.60%18.82%
-17.52%21.92%
5.35%25.74%
-5.35%24.90%
-0.74%26.74%
35.47%26.58%
4.72%24.43%
-43.60%26.30%
--26.93%
--19.62%
--23.33%
--46.64%
----
----
----
----
----
----
Gross Margin
-0.08%77.46%
-0.82%78.01%
-0.97%78.15%
-3.49%77.77%
-2.95%77.52%
0.29%78.65%
-1.58%78.91%
0.93%80.59%
-0.36%79.88%
1.29%78.43%
-34.80%80.18%
--79.85%
--80.17%
--77.43%
--122.98%
----
----
----
----
----
----
Debt to assets ratio
----
-2.13%4.49%
-4.59%4.37%
-2.15%4.51%
-25.04%4.43%
-25.16%4.59%
-28.20%4.58%
-27.67%4.61%
-10.76%5.91%
-11.04%6.13%
-11.33%6.38%
--6.37%
--6.63%
--6.89%
--7.19%
----
----
----
----
----
----
Revenue
13.63%1.74B
16.70%1.65B
13.26%1.57B
14.67%1.55B
10.56%1.53B
-11.61%1.41B
-9.67%1.39B
8.93%1.35B
6.98%1.39B
9.50%1.60B
13.78%1.53B
-5.73%1.24B
-5.71%1.30B
8.83%1.46B
1.40%1.35B
0.67%1.32B
-0.15%1.37B
10.24%1.34B
11.58%1.33B
14.84%1.31B
----
Operating profit
31.75%567.70M
25.57%514.70M
4.81%370.30M
7.81%425.10M
14.24%430.90M
-6.35%409.90M
-17.30%353.30M
7.12%394.30M
-1.90%377.20M
1.18%437.70M
-4.47%427.20M
-19.26%368.10M
-13.54%384.50M
-2.35%432.60M
23.06%447.20M
15.10%455.90M
0.63%444.70M
14.95%443.00M
0.61%363.40M
10.89%396.10M
----
Net Profit
-27.40%241.90M
6.34%380.70M
-76.35%91.20M
-90.52%291.10M
-9.04%333.20M
1.73%358.00M
4.24%385.60M
697.82%3.07B
19.28%366.30M
3.35%351.90M
-7.15%369.90M
12.05%384.90M
-24.43%307.10M
-8.86%340.50M
18.82%398.40M
1.00%343.50M
-16.98%406.40M
10.47%373.60M
8.34%335.30M
4.58%340.10M
----
Current assets
----
0.26%6.23B
7.22%6.74B
-5.48%6.36B
45.64%6.58B
48.97%6.21B
55.74%6.29B
65.40%6.73B
23.83%4.52B
28.04%4.17B
30.36%4.04B
15.75%4.07B
11.76%3.65B
0.49%3.26B
-2.67%3.10B
-0.05%3.51B
-1.80%3.26B
5.61%3.24B
2.90%3.18B
17.95%3.52B
23.51%3.32B
Total current liabilities
----
1.02%1.41B
20.50%1.81B
-18.32%1.59B
15.42%1.40B
25.57%1.39B
25.92%1.51B
56.92%1.94B
5.17%1.22B
2.66%1.11B
16.92%1.20B
34.97%1.24B
19.41%1.16B
13.91%1.08B
-0.96%1.02B
-5.03%917.90M
9.35%969.10M
18.89%949.90M
15.48%1.03B
14.20%966.50M
1.49%886.20M
Total assets
----
2.30%13.32B
4.92%13.70B
2.32%13.27B
33.56%13.49B
33.75%13.02B
39.43%13.06B
38.42%12.97B
12.16%10.10B
12.54%9.74B
12.91%9.36B
8.48%9.37B
6.87%9.00B
2.75%8.65B
-2.47%8.29B
5.86%8.64B
9.96%8.43B
16.72%8.42B
17.49%8.50B
19.99%8.16B
19.27%7.66B
Total liabilities
----
5.76%2.99B
12.27%3.36B
-8.71%3.07B
11.08%2.88B
11.01%2.83B
13.19%2.99B
27.09%3.36B
1.45%2.59B
-1.52%2.55B
6.36%2.64B
9.23%2.64B
3.06%2.56B
0.55%2.59B
-6.78%2.49B
-7.58%2.42B
-1.87%2.48B
0.77%2.58B
0.15%2.67B
1.10%2.62B
-2.17%2.53B
Total equity
----
1.33%10.33B
2.73%10.34B
6.18%10.21B
41.33%10.61B
41.82%10.19B
49.76%10.06B
42.88%9.61B
16.41%7.50B
18.55%7.19B
15.72%6.72B
8.19%6.73B
8.46%6.45B
3.71%6.06B
-0.50%5.81B
12.21%6.22B
15.79%5.94B
25.47%5.84B
27.58%5.84B
31.61%5.54B
33.71%5.13B
Net operating income
----
-84.38%43.80M
453.65%450.90M
63.08%573.70M
-21.88%290.20M
624.11%280.40M
-193.34%-127.50M
-14.51%351.80M
1005.65%371.50M
-117.03%-53.50M
-51.70%136.60M
32.78%411.50M
-89.89%33.60M
7.09%314.10M
-24.30%282.80M
-41.74%309.90M
-36.86%332.20M
-2.40%293.30M
-6.60%373.60M
146.14%531.90M
127.55%526.10M
Net investment
----
-208.79%-92.80M
65.61%-198.30M
-115.83%-427.80M
-237.90%-172.10M
35.18%85.30M
-4190.07%-576.70M
2935.62%2.70B
77.78%124.80M
12520.00%63.10M
-85.11%14.10M
144.17%89.00M
-45.83%70.20M
-99.78%500.00K
109.80%94.70M
46.61%-201.50M
139.33%129.60M
561.77%229.50M
-271.64%-965.90M
-198.81%-377.40M
-3130.39%-329.50M
Net financing
----
-74.88%-451.20M
-139.86%-11.40M
24.22%-740.10M
154.55%52.70M
-518.15%-258.00M
106.92%28.60M
-581.58%-976.70M
-285.41%-96.60M
129.86%61.70M
50.72%-413.20M
-105.01%-143.30M
116.91%52.10M
43.87%-206.60M
-1252.26%-838.40M
-279.23%-69.90M
-422.20%-308.10M
-34.20%-368.10M
-249.76%-62.00M
14.71%39.00M
-344.81%-59.00M

FAQs

What is the total revenue of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its total revenue reached 6.07B, with a year-on-year change of 5.44B.

What are the current assets of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its current assets were 6.74B, with a year-on-year change of 7.22.

What are the total assets of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its total assets of Edwards Lifesciences Corp were 13.70B, with a year-on-year change of 4.92.

What are the total liabilities of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its total liabilities of Edwards Lifesciences Corp were 3.36B, with a year-on-year change of 12.27.

What is the total equity of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its total equity of Edwards Lifesciences Corp was 10.34B, with a year-on-year change of 2.73.

What is the net operating income of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its net operating income of Edwards Lifesciences Corp was 1.64B, with a year-on-year change of 10.55.

What is the net investment of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its net investment of Edwards Lifesciences Corp was -712.90M, with a year-on-year change of -130.82.

What is the net financing of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its net financing of Edwards Lifesciences Corp was -956.80M, with a year-on-year change of 2.67.

What is the Earnings Per Share (EPS) of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its Earnings Per Share (EPS) was 1.84, with a year-on-year change of -73.72.

What is the net income of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its net income was 1.07B, with a year-on-year change of -74.28.

What is the net margin of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its net profit margin was 17.40, with a year-on-year change of -32.19.

What is the gross margin of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its gross margin was 78.01, with a year-on-year change of -1.82.

What is the debt-to-asset ratio of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its debt-to-asset ratio was 4.37, with a year-on-year change of -4.59.

What is the Return on Equity (ROE) of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its Return on Equity (ROE) was 10.43, with a year-on-year change of -38.05.

What is the Return on Assets (ROA) of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its Return on Assets (ROA) was 7.89, with a year-on-year change of -36.61.

What is the operating profit of Edwards Lifesciences Corp?

According to Edwards Lifesciences Corp's FY2025 earnings report, its operating profit was 1.64B, with a year-on-year change of 10.55.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.